The role of teprotumumab in chronic, clinically active thyroid eye disease.

Yu, Caroline Y; Simmons, Brittany A; Pham, Chau M; Shriver, Erin M

Yu, Caroline Y; Simmons, Brittany A; Pham, Chau M; Shriver, Erin M.

Afiliação

Yu CY; University of Iowa Hospital and Clinics, Department of Ophthalmology and Visual Sciences, Iowa City, IA, 52240, USA.
Simmons BA; University of Iowa Hospital and Clinics, Department of Ophthalmology and Visual Sciences, Iowa City, IA, 52240, USA.
Pham CM; University of Iowa Hospital and Clinics, Department of Ophthalmology and Visual Sciences, Iowa City, IA, 52240, USA.
Shriver EM; University of Iowa Hospital and Clinics, Department of Ophthalmology and Visual Sciences, Iowa City, IA, 52240, USA. erin-shriver@uiowa.edu.

Eye (Lond) ; 36(7): 1500-1501, 2022 07.

Article em En | MEDLINE | ID: mdl-34983925

Assuntos

Exoftalmia; Oftalmopatia de Graves; Anticorpos Monoclonais Humanizados/uso terapêutico; Oftalmopatia de Graves/tratamento farmacológico; Humanos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Exoftalmia / Oftalmopatia de Graves Limite: Humans Idioma: En Revista: Eye (Lond) Assunto da revista: OFTALMOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google